Jalyn is a comparatively new drug. It was approved by FDA on June 14, 2010. It is a combination of dutasteride and tamsulosin and used for treatment of symptomatic benign hyperplasia in men with enlarged prostate.
source: Drugs.com
source: Drugs.com